Imidazole → 4-Bromophenyl-tert-butyldimethylsilyl ether

HRID 233750

반응식

HRID 233750 반응식
[Br:1][C:2]1[CH:7]=[CH:6][C:5](O)=[CH:4][CH:3]=1.N1[CH:13]=[CH:12]N=C1.[Si:14](Cl)([C:17]([CH3:20])([CH3:19])[CH3:18])([CH3:16])[CH3:15].[OH2:22]>CN(C=O)C>[Br:1][C:2]1[CH:7]=[CH:6][C:5]([CH2:15][Si:14]([O:22][Si:14]([CH2:16][C:13]2[CH:12]=[CH:7][C:2]([Br:1])=[CH:3][CH:4]=2)([CH3:15])[C:17]([CH3:20])([CH3:19])[CH3:18])([C:17]([CH3:20])([CH3:19])[CH3:18])[CH3:16])=[CH:4][CH:3]=1

참가 물질

6

반응물 4

HCID 795ImidazoleHCID 962WaterHCID 78084-BromophenolHCID 28928tert-Butyldimethylsilyl chloride

생성물 1

HCID 688013174-Bromophenyl-tert-butyldimethylsilyl ether

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

4-Bromophenol (5.76 g, 30 mmol), imidazole (4.08 g, 60 mmol) and tert-butyldimethylsilyl chloride (5.02 g, mmol) were stirred in anhydrous DMF (100 mL) at 25° C. for h. The reaction mixture was then poured into water (100 mL) and extracted with ethyl acetate (2×75 mL). The combined extracts were washed with water (2×75 mL), brine (75 mL) and dried (MgSO4) before concentration in vacuo. The crude product was purified using "flash" silica gel column chromatography with ethyl acetate:hexane (1:4) as eluant to afford the title compound as an oil, 7.9 g, 92%. 1H NMR (CDCl3, 300 MHz): δ 7.33 (app. dt, J=9, 3, 1 Hz, 2 H), 6.73 (app. dt, J=9, 3, 1 Hz, 2 H) 0.98 (s, 9 H),0.21 (s, 6 H).

후처리

  1. extractionextracted with ethyl acetate (2×75 mL)
  2. washThe combined extracts were washed with water (2×75 mL), brine (75 mL)
  3. dry with materialdried (MgSO4)
  4. concentrationbefore concentration in vacuo
  5. customThe crude product was purified

출처 및 근거

ORD 기록
ord-34146178088c4f21984a9d03e136fc27
출처 데이터셋
uspto-grants-1997_01
특허 번호
US05594011

연결된 노트

불러오는 중…